Frontlight ResearchEarly access
Trial site
CHU de Quebec-Hopital du Saint-Sacrement (HSS)
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer2 trials
- Ovarian cancer1 trial
- Phase
- Phase 33 trials
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Alliance for Clinical Trials in Oncology1 trial
- National Cancer Institute (NCI)1 trial
- NRG Oncology1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026